Comparison of two chromogenic FVIII activity assays to a standard clot-based FVIII activity assay

被引：0
|
作者：
McGlasson, D. L. [1 ]
Fritsma, G. A. [2 ]
机构：
[1] 59th Clin Res Div, Lab Serv, Lackland AFB, TX USA
[2] Fritsma Factor, Hemostasis Connect, Birmingham, AL USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-WE-235
引用
收藏
页码：706 / 706
页数：1
相关论文
共 50 条
  • [41] PERFORMANCE OF A NEW KIT FOR A MODIFIED NIJMEGEN-BETHESDA ASSAY: COMPARISON OF A CHROMOGENIC VERSUS A CLOT-BASED FACTOR VIII INHIBITOR ASSAY IN PLASMA FROM PERSONS WITH HEMOPHILIA A (PWHA)
    Sadeghi-Khomami, Ali
    Boylan, Marc
    Chen, David C.
    Adamkewicz, Joanne I.
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E55 - E55
  • [42] Fondaparinux anti-Xa activity: a comparison of one clotting assay and chromogenic substrate assays.
    Van Dreden, P
    Depasse, F
    Gerotziafas, GT
    Busson, J
    Fontaine, S
    Samama, MM
    BLOOD, 2003, 102 (11) : 120B - 121B
  • [43] FVIII activity of long-acting turoctocog alfa pegol (N8-GP) can be accurately and precisely measured by different commercial chromogenic assays
    Pickering, W.
    Hansen, M.
    Ezban, M.
    Kjalke, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 561 - 561
  • [44] COMPARISON OF NEPHELOMETRIC AND COAGULOMETRIC METHODS FOR PROTEIN-C DETERMINATION - EVALUATION OF 3 CLOT-BASED ASSAYS
    LEDFORD, MR
    BRITO, MI
    CIVANTOS, F
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 661 - 661
  • [45] The Use of Activated Partial Thromboplastin Time As a Surrogate to Predict Residual FVIII Activity in the Bethesda Assay
    De Simone, Nicole
    Sarode, Ravi
    BLOOD, 2016, 128 (22)
  • [46] WHICH TYPE OF FVIII ACTIVITY ASSAY BEST REFLECTS THE "TRUE" POTENCY OF RVIII-SINGLECHAIN?
    Horn, C.
    Zollner, S.
    Meyers, W.
    Metzner, H. J.
    HAEMATOLOGICA, 2016, 101 : 11 - 12
  • [47] Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies
    Kitchen, Steve
    Tiefenbacher, Stefan
    Gosselin, Robert
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 331 - 337
  • [48] Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study
    Hillarp, A.
    Bowyer, A.
    Ezban, M.
    Persson, P.
    Kitchen, S.
    HAEMOPHILIA, 2017, 23 (03) : 458 - 465
  • [49] Biological Activity Analysis of Native and Recombinant Streptokinase Using Clot Lysis and Chromogenic Substrate Assay
    Mahboubi, Arash
    Sadjady, Seyyed Kazem
    Abadi, Mohammad Mirzaei Saleh
    Azadi, Saeed
    Solaimanian, Roya
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2012, 11 (04): : 1087 - 1093
  • [50] Evaluation of discrepancy between clot-based and chromogenic factor IX coagulation assays in non-severe hemophilia B patients and identification of the causing mutations
    Mahdavimand, Mahdieh
    Tabibian, Shadi
    Zafarani, Alireza
    Manafi, Rima
    Barati, Mahmood
    Safa, Majid
    TRANSFUSION AND APHERESIS SCIENCE, 2025, 64 (01)
12345